Millipore Sigma Vibrant Logo

505016 CX546 - CAS 215923-54-9 - Calbiochem

505016
View Pricing & Availability

Overview

Replacement Information

Key Specifications Table

Empirical FormulaCAS #
C₁₄H₁₇NO₃ 215923-54-9

Pricing & Availability

Catalog Number AvailabilityPackaging Qty/Pack Price Quantity
5.05016.0001
Retrieving availability...
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Glass bottle 10 mg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity is a multiple of
      Maximum Quantity is
      Upon Order Completion More Information
      You Saved ()
       
      Request Pricing
      Description
      OverviewA positive allosteric modulator selective for the AMPA receptors. Used in studies related to Schizophrenia, neuroplasticity, Autism and neuronal differentiation.
      Catalogue Number505016
      Brand Family Calbiochem®
      SynonymsAMPA Positive Allosteric Modulator, CX546, CX-546, CX 546
      References
      ReferencesSilverman, L., et al. 2013. Neuropharmacol. 64, 268.
      Peleg-Raibstein, D., et al. 2012. Curr. Antipsych. 2012, 361.
      Schitine, C., et al. 2012. Eur. J. Neurosci. 35, 1672.
      Lipina, T., et al. 2006. Neuropsychopharmacology. 32, 745.
      Arai, C., et al. 2004. Neurosci. 123, 1011.
      Nagarajan, N., et al. 2001. Neuropharmacol. 41, 650.
      Product Information
      CAS number 215923-54-9
      FormOff-white solid
      Hill FormulaC₁₄H₁₇NO₃
      Chemical formulaC₁₄H₁₇NO₃
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetAMPA
      Purity≥98% by TLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      CX546 - CAS 215923-54-9 - Calbiochem SDS

      Title

      Safety Data Sheet (SDS) 

      References

      Reference overview
      Silverman, L., et al. 2013. Neuropharmacol. 64, 268.
      Peleg-Raibstein, D., et al. 2012. Curr. Antipsych. 2012, 361.
      Schitine, C., et al. 2012. Eur. J. Neurosci. 35, 1672.
      Lipina, T., et al. 2006. Neuropsychopharmacology. 32, 745.
      Arai, C., et al. 2004. Neurosci. 123, 1011.
      Nagarajan, N., et al. 2001. Neuropharmacol. 41, 650.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision12-September-2013 JSW
      SynonymsAMPA Positive Allosteric Modulator, CX546, CX-546, CX 546
      DescriptionA positive allosteric modulator selective for the AMPA receptors. Used in studies related to Schizophrenia, neuroplasticity, Autism and neuronal differentiation.
      FormOff-white solid
      CAS number 215923-54-9
      Chemical formulaC₁₄H₁₇NO₃
      Structure formulaStructure formula
      Purity≥98% by TLC
      SolubilityDMSO
      Storage +2°C to +8°C
      Protect from light
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesSilverman, L., et al. 2013. Neuropharmacol. 64, 268.
      Peleg-Raibstein, D., et al. 2012. Curr. Antipsych. 2012, 361.
      Schitine, C., et al. 2012. Eur. J. Neurosci. 35, 1672.
      Lipina, T., et al. 2006. Neuropsychopharmacology. 32, 745.
      Arai, C., et al. 2004. Neurosci. 123, 1011.
      Nagarajan, N., et al. 2001. Neuropharmacol. 41, 650.